In a study of over 91,000 adults: Cannabis users showed a lower overall risk of metabolic disorders About 20% lower likelihood of type 2 diabetes Over 40% lower likelihood of obesity Stronger effects seen in individuals with lower body weight Important: This study shows a link, not cause-and-effectmore research is still needed
Do not store the Estradiol Transdermal System patches outside of their pouches
Heres what scientists do understand: GLP-1 medications mimic naturally existing glucagon-like peptide 1 gut hormones in your bodymostly secreted in the small intestine and pancreasthat help regulate blood sugar and appetite
[ Disclaimer: This article is for informational purposes only and does not constitute medical advice
Marketed under the brand names Ozempic (for type 2 diabetes) and Wegovy (for weight loss), this GLP-1 receptor agonist has redefined the landscape of chronic weight management
Safety and pharmacokinetics of single and multiple ascending doses of the novel oral human GLP-1 analogue, oral semaglutide in healthy subjects and subjects with type 2 diabetes